| 焦虑障碍的药物治疗进展 |
| |
| 引用本文： | 顾宝东,丰广魁,汤灵翼.焦虑障碍的药物治疗进展[J].大连医科大学学报,2014,36(4):400-404. |
| |
| 作者姓名： | 顾宝东 丰广魁 汤灵翼 |
| |
| 作者单位： | 1.连云港市中医院 脑病科，江苏 连云港 222004；2.南京中医药大学，江苏 南京 210023 |
| |
| 摘 要： | 目前对焦虑障碍缺乏统一的诊断标准，国内外指南的分型和治疗用药不尽相同。一般认为焦虑障碍的一线用药为SSRIs、SNRIs，部分指南推荐普瑞巴林可以作为一线药物，难治性焦虑障碍可在抗抑郁药基础上加二线药物，或者非经典抗精神病药物、抗抽搐药物等，常规治疗时间一般在12～18个月，对于广泛性焦虑障碍（ gen eral-ized anxiety disorder ，GAD）甚至需要终身治疗。
|
| 关 键 词： | 焦虑障碍 药物治疗 进展 |
| 收稿时间： | 2013/8/16 0:00:00 |
| 修稿时间： | 2014/4/10 0:00:00 |
Developments in the drug treatment of anxiety disorder |
| |
| GU Bao-dong,FENG Guang-kui,TANG Ling-yi.Developments in the drug treatment of anxiety disorder[J].Journal of Dalian Medical University,2014,36(4):400-404. |
| |
| Authors: | GU Bao-dong FENG Guang-kui TANG Ling-yi |
| |
| Institution: | GU Bao-dong, FENG Guang-kui, TANG Ling-yi ( 1. Neurology,Lianyungang Hospital of Traditional Chinese Medicine, Lianyungang 222004, China ; 2. Nanjing University of Chinese Medicine,Nanfing 210023, China ) |
| |
| Abstract: | Due to lack of uniform diagnostic criteria , the domestic and international cclassification and treatment guide-lines of anxiety disorders vary a lot currently .It is generally recognized that SSRIs and SNRIs are the first -line treatment of anxiety disorders.In addition, a minority of guidelines recommend pregabalin as the first -line drug.Refractory anxiety disorders can be treated by a combination of antidepressants with second -line drugs, non -classical antipsychotics or anti-convulsive drugs.Conventional treatment cycles are generally between 12 to 18 months.Lifelong treatment may be e-ven necessary for GAD . |
| |
| Keywords: | [Key words] anxiety disorder drug treatment progress |
| 本文献已被 维普 等数据库收录！ |
| 点击此处可从《大连医科大学学报》浏览原始摘要信息 |
| 点击此处可从《大连医科大学学报》下载免费的PDF全文 |
